PMID- 26753957 OWN - NLM STAT- MEDLINE DCOM- 20170206 LR - 20191210 IS - 1423-0380 (Electronic) IS - 1010-4283 (Linking) VI - 37 IP - 7 DP - 2016 Jul TI - High expression of constitutive photomorphogenic 1 (COP1) is associated with poor prognosis in bladder cancer. PG - 8917-22 LID - 10.1007/s13277-015-4765-4 [doi] AB - The present study was to investigate the expression and prognostic value of constitutive photomorphogenic 1 (COP1) in bladder cancer. In our study, real-time quantitative PCR (RT-PCR) was performed to detect 10 pairs of fresh bladder cancer (BCa) and adjacent noncancerous tissues. In addition, immunohistochemistry was utilized to detect the expression of COP1 in 174 clinical bladder cancer samples. What is more, the correlation of COP1 expression and clinicopathological features and clinical outcomes were analyzed. The expression levels of COP1 in clinical bladder cancer were much higher than that in paired adjacent noncancerous tissues (p < 0.0001). High expression of COP1 was closely related with differentiation (p = 0.040) and recurrence (p = 0.001) of patients with bladder cancer. Kaplan-Meier analysis revealed that the expression of COP1 was closely correlated with overall survival (p = 0.048) of bladder cancer, while, recurrence-free survival (p = 0.201). Moreover, Cox multivariate regression analyses showed that COP1 expression was an independent predictor of overall survival (OS; p = 0.027, hazard ratio = 2.127, confidence interval 0.814 to 9.736). Based on our data, the present study suggests that high expression of COP1 may be a novel biological indicator for evaluation of poor prognosis in bladder cancer. FAU - Li, Jianlong AU - Li J AD - Department of Urology, the Second Affiliated Hospital of Nanchang University, 330006, Nanchang, Jiangxi Province, People's Republic of China. FAU - Wang, Longwang AU - Wang L AD - Department of Urology, the Second Affiliated Hospital of Nanchang University, 330006, Nanchang, Jiangxi Province, People's Republic of China. FAU - Xiao, Ruihai AU - Xiao R AD - Department of Urology, the Second Affiliated Hospital of Nanchang University, 330006, Nanchang, Jiangxi Province, People's Republic of China. FAU - Pan, Qiufeng AU - Pan Q AD - Department of Urology, the Second Affiliated Hospital of Nanchang University, 330006, Nanchang, Jiangxi Province, People's Republic of China. FAU - Huang, Hongwei AU - Huang H AD - Department of Urology, the Second Affiliated Hospital of Nanchang University, 330006, Nanchang, Jiangxi Province, People's Republic of China. FAU - Kuang, Renrui AU - Kuang R AD - Department of Urology, the Second Affiliated Hospital of Nanchang University, 330006, Nanchang, Jiangxi Province, People's Republic of China. kuangrenruiapple@126.com. LA - eng PT - Journal Article DEP - 20160111 PL - Netherlands TA - Tumour Biol JT - Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine JID - 8409922 RN - EC 2.3.2.27 (COP1 protein, human) RN - EC 2.3.2.27 (Ubiquitin-Protein Ligases) SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Disease-Free Survival MH - Female MH - Gene Expression Regulation, Neoplastic/genetics MH - Humans MH - Immunohistochemistry/methods MH - Kaplan-Meier Estimate MH - Male MH - Middle Aged MH - Neoplasm Recurrence, Local/genetics/pathology MH - Prognosis MH - Regression Analysis MH - Ubiquitin-Protein Ligases/*genetics MH - Urinary Bladder Neoplasms/*genetics/*pathology OTO - NOTNLM OT - Bladder cancer OT - COP1 expression OT - Prognosis EDAT- 2016/01/13 06:00 MHDA- 2017/02/07 06:00 CRDT- 2016/01/13 06:00 PHST- 2015/11/02 00:00 [received] PHST- 2015/12/29 00:00 [accepted] PHST- 2016/01/13 06:00 [entrez] PHST- 2016/01/13 06:00 [pubmed] PHST- 2017/02/07 06:00 [medline] AID - 10.1007/s13277-015-4765-4 [pii] AID - 10.1007/s13277-015-4765-4 [doi] PST - ppublish SO - Tumour Biol. 2016 Jul;37(7):8917-22. doi: 10.1007/s13277-015-4765-4. Epub 2016 Jan 11.